Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy

ACS Appl Mater Interfaces. 2020 Nov 18;12(46):51249-51262. doi: 10.1021/acsami.0c15211. Epub 2020 Nov 8.

Abstract

Glucose oxidase (GOx)-mediated starvation therapy has demonstrated good application prospect in cancer treatment. However, the glucose- and oxygen-depletion starvation therapy still suffers from some limitations like low therapeutic efficiency and potential side effects to normal tissues. To overcome these disadvantages, herein a novel enzymatic cascade nanoreactor (Pd@Pt-GOx/hyaluronic acid (HA)) with controllable enzymatic activities was developed for high-efficiency starving-enhanced chemodynamic cancer therapy. The Pd@Pt-GOx/HA was fabricated by covalent conjugation of GOx onto Pd@Pt nanosheets (NSs), followed by linkage with hyaluronic acid (HA). The modification of HA on Pd@Pt-GOx could block the GOx activity, catalase (CAT)-like and peroxidase (POD)-like activities of Pd@Pt, reduce the cytotoxicity to normal cells and organs, and effectively target CD44-overexpressed tumors by active targeting and passive enhanced permeability and retention (EPR) effect. After endocytosis by tumor cells, the intracellular hyaluronidase (Hyase) could decompose the outer HA and expose Pd@Pt-GOx for the enzymatic cascade reaction. The GOx on the Pd@Pt-GOx could catalyze the oxidation of intratumoral glucose by O2 for cancer starvation therapy, while the O2 produced from the decomposition of endogenous H2O2 by the Pd@Pt with the CAT-like activity could accelerate the O2-dependent depletion of glucose by GOx. Meanwhile, the upregulated acidity and H2O2 content in the tumor region generated by GOx catalytic oxidation of glucose dramatically facilitated the pH-responsive POD-like activity of the Pd@Pt nanozyme, which then catalyzed degradation of the H2O2 to generate abundant highly toxic OH, thereby realizing nanozyme-mediated starving-enhanced chemodynamic cancer therapy. In vitro and in vivo results indicated that the controllable, self-activated enzymatic cascade nanoreactors exerted highly efficient anticancer effects with negligible biotoxicity.

Keywords: Pd@Pt-GOx/HA nanoreactors; chemodynamic therapy; enzymatic cascade reaction; starvation therapy; tumor targeting.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Biocatalysis
  • Biocompatible Materials / chemistry*
  • Biocompatible Materials / pharmacokinetics
  • Biocompatible Materials / pharmacology
  • Biocompatible Materials / therapeutic use
  • Cell Line, Tumor
  • Glucose / chemistry
  • Glucose / metabolism
  • Glucose Oxidase / chemistry
  • Glucose Oxidase / metabolism*
  • Hyaluronic Acid / chemistry*
  • Hydrogen Peroxide / chemistry
  • Hydrogen Peroxide / metabolism
  • Hydrogen-Ion Concentration
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Mice
  • Nanostructures / chemistry*
  • Nanostructures / therapeutic use
  • Nanostructures / toxicity
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Oxygen / chemistry
  • Palladium / chemistry*
  • Platinum / chemistry*
  • Reactive Oxygen Species / metabolism
  • Tissue Distribution
  • Transplantation, Homologous

Substances

  • Biocompatible Materials
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Reactive Oxygen Species
  • Platinum
  • Palladium
  • Hyaluronic Acid
  • Hydrogen Peroxide
  • Glucose Oxidase
  • Glucose
  • Oxygen